Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 5 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 hours agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 7 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
Kendrick-Holmes: Why I thought of MerleFest when I got a prescription for Paxlovid
Winston-Salem Journal· 4 days agoYes, I had COVID. When the friendly nurse practitioner broke the news, I immediately thought of...
Here’s what local experts are saying about new COVID-19 variants
WPXI via Yahoo News· 2 days agoAccording to Adalja, FLiRT will have similar symptoms to all previous versions of COVID-19 — cough, cold-like-symptoms, muscle aches and pains, fevers, headaches, and sore ...
Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup
Market Watch· 7 days agoHealth-care companies rose after generally strong earnings. Pfizer shares surged, rising by more than 5%, after the drug giant said sales of blood thinner...
Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds
Center for Infectious Disease Research and Policy· 5 days agoToday, researchers from the University of Minnesota published evidence that the common diabetes drug...
Doctors seeking 'long COVID' patients for clinical trial: HealthLink
KING5 Seattle· 5 days agoFor most of us, COVID-19 is a thing of the past, but for others, COVID has stayed with them...
Pfizer beats earnings estimates months after stock dipped to record lows
Crain's New York Business· 7 days agoAlthough sales of Paxlovid tumbled, they declined slower than investors expected, in part because of a $771 million favorable adjustment to estimated sales declines after ...